Operating Lease, Right-of-Use Asset of TEVA PHARMACEUTICAL INDUSTRIES LTD from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TEVA PHARMACEUTICAL INDUSTRIES LTD quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $342,000,000, a 6% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $342,000,000 -$22,000,000 -6% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $358,000,000 $0 0% 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $363,000,000 -$1,000,000 -0.28% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $367,000,000 -$30,000,000 -7.6% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $364,000,000 -$42,000,000 -10% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $358,000,000 -$60,000,000 -14% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 $364,000,000 -$56,000,000 -13% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $397,000,000 -$22,000,000 -5.3% 31 Dec 2023 10-K 05 Feb 2025 2024 FY
Q3 2023 $406,000,000 -$16,000,000 -3.8% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $418,000,000 -$23,000,000 -5.2% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $420,000,000 -$44,000,000 -9.5% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $419,000,000 -$76,000,000 -15% 31 Dec 2022 10-K 12 Feb 2024 2023 FY
Q3 2022 $422,000,000 -$85,000,000 -17% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $441,000,000 -$90,000,000 -17% 30 Jun 2022 10-Q 27 Jul 2022 2022 Q2
Q1 2022 $464,000,000 -$65,000,000 -12% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $495,000,000 -$64,000,000 -11% 31 Dec 2021 10-K 10 Feb 2023 2022 FY
Q3 2021 $507,000,000 -$50,000,000 -9% 30 Sep 2021 10-Q 27 Oct 2021 2021 Q3
Q2 2021 $531,000,000 +$42,000,000 +8.6% 30 Jun 2021 10-Q 28 Jul 2021 2021 Q2
Q1 2021 $529,000,000 +$40,000,000 +8.2% 31 Mar 2021 10-Q 28 Apr 2021 2021 Q1
Q4 2020 $559,000,000 +$45,000,000 +8.8% 31 Dec 2020 10-K 09 Feb 2022 2021 FY
Q3 2020 $557,000,000 +$89,000,000 +19% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $489,000,000 -$11,000,000 -2.2% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $489,000,000 -$28,000,000 -5.4% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $514,000,000 31 Dec 2019 10-K 10 Feb 2021 2020 FY
Q3 2019 $468,000,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $500,000,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $517,000,000 31 Mar 2019 10-Q 02 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.